atai Life Sciences Announces Positive Data For Orally Administered MDMA Derivative EMP-01 Jan 2, 2024
Christian Angermayer On His Continued Belief In The Psychedelic Sector and Atai Life Sciences Apr 4, 2023
Apeiron Founder Christian Angermayer Makes Follow-On Purchase Of Atai Life Sciences Shares Mar 30, 2023
atai Life Sciences Investor Christian Angermayer Addresses Recent Trial Results And Pipeline Outlook Jan 13, 2023
atai Life Sciences Investor Christian Angermayer On The Company’s Low Valuation And Late-Stage Pipeline Nov 16, 2022
